Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute oral buspirone for ineffective esophageal motility
2010-021390-36Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of buspirone in Ineffective Esophageal Motility (IEM), sponsored by UZ Leuven. Primary endpoint: Mean esophageal pressure wave amplitude. Started Jun 2010; status: completed.
02
Drugs
buspirone
03
Conditions
Ineffective Esophageal Motility (IEM)
Beyond the preview
Go deeper on 2010-021390-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021390-36.